Selank 10mg

CLASSIFICATION Anxiolytic Peptide
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Beligas
WAREHOUSE International Warehouse 3
SUBSTANCE Selank

In the rapidly evolving world of biotechnology, innovative biologically-active substances, including ?cognitive enhancers? or ?nootropics,? are gaining attention.

One standout compound in this realm is Selank, previously known as ?TP-7.? This synthetic peptide is expertly engineered to mimic natural proteins and is making waves as an effective anxiolytic.

Marketed for its potential to combat anxiety, Selank promises to enhance learning and energize without the side effects or addiction risks typically associated with such substances. Developed by the Institute of Molecular Genetics (Russian Academy of Sciences) in partnership with the V.V. Zakusov Research Institute of Pharmacology, it works in tandem with a similar drug called Semax.

Selank's creation involves a combination of tuftsin, a naturally occurring peptide found in the antibody IgG, and a sequence that boosts its molecular stability.

Studies have indicated that both tuftsin and Selank can effectively reduce anxiety and elevate serotonin levels in animal models, with Selank demonstrating slightly superior efficacy.

In Russia, Selank is approved for treating generalized anxiety disorder (GAD) and is recognized for its nootropic effects, although it's not FDA-approved in the U.S. Nonetheless, it's available in various countries, often marketed as a ?nutritional supplement.?

While the exact mechanisms of Selank are still being explored, it is believed to stabilize enkephalins in the bloodstream?natural peptides that help manage stress responses.

However, some studies in mice have not shown enkephalin stabilization or significant anti-anxiety effects post-administration.

Other cellular research suggests that Selank may interact with GABA receptors, commonly associated with sedative properties. A study indicated that Selank boosts activity in GABA-dependent inhibitory neurons, leading to reduced overall brain activity consistent with sedative effects.

Moreover, some observations suggest an increase in BDNF, a crucial neurotrophic factor tied to learning and memory, hinting at cognitive benefits. Selank has also been shown to impact levels of neurotransmitters like norepinephrine, dopamine, and serotonin?key players in motivation, focus, and pleasure.

Results vary across studies, indicating that Selank may raise norepinephrine levels while lowering dopamine and serotonin in some cases, while other findings suggest it elevates both norepinephrine and dopamine without altering serotonin. Thus, the precise effects and mechanisms of Selank remain somewhat unclear.

In a preliminary clinical trial involving 62 participants, those treated with Selank reported a reduction in anxiety symptoms, especially among individuals with pre-existing anxiety disorders.

Another study with 60 patients experiencing anxiety and phobias noted lasting benefits for up to a week after treatment.

Furthermore, Selank appeared to enhance the effects of phenazepam (an anti-anxiety medication banned in some U.S. states) while minimizing adverse effects such as drowsiness and memory loss.

Animal studies have also highlighted Selank's potential in alleviating anxiety in mice, particularly among the more anxious individuals, with notable results observed after four weeks of treatment.

While evidence remains limited, it suggests that Selank may help ease anxiety; however, further research is essential to confirm its efficacy and safety for human use. If you're grappling with anxiety, consult your healthcare provider about the potential advantages of Selank, always adhering to their medical guidance and prescriptions.

One study indicated that Selank might stabilize memory traces in rats over a 30-day period, although the methodology behind these measurements remains unclear, given that memory traces aren't distinctly located in the brain.

Another investigation suggested that Selank could help preserve memory in monkeys.

However, human studies are limited, leaving uncertainty about its effects on healthy individuals, and further research is needed to ensure safety for both short- and long-term use.

In a noteworthy study, Selank administration to rats with toxin-induced brain damage was associated with the restoration of normal brain activity levels.

Selank has shown promise in reducing depressive symptoms (as evidenced by decreased immobility in forced swimming tests) in mice, with increased effectiveness observed at lower dosages.

Preliminary animal studies have indicated that Selank injections elevated antioxidant levels in the livers of stressed mice.

In a study involving sedated cats, Selank was found to lower blood pressure by approximately 30% for up to three minutes while boosting cerebral blood flow by around 24% for ten minutes.

While these findings hint at short-term cardiovascular effects, the brief duration makes interpretations challenging, suggesting the effects may not be robust or clinically significant. Furthermore, these results remain unverified in healthy human subjects.

Given that anxiety often accompanies alcohol withdrawal, a study demonstrated that Selank alleviated anxiety levels in rats following 48 hours of withdrawal from a 10% ethanol solution consumed over 24 weeks.

In one animal study, rats on a high-fat diet exhibited 35% less weight gain with Selank treatment, alongside significant reductions in total cholesterol (over 58%) and blood glucose levels (by 23.5%).

In a preliminary study involving breast cancer-infected mice, those treated with daily Selank doses displayed slower tumor growth and increased survival rates compared to untreated counterparts.

However, these results do not imply that Selank is a viable option for cancer therapy, and extensive research is necessary to validate these findings for legitimate cancer treatment. Selank should not be used as a substitute for standard cancer therapies.

Post-treatment with Selank, mice exhibited elevated levels of several inflammatory response genes in their spleens, indicating potential protection against inflammation-related damage.

Selank has been indicated to reduce stomach ulcer size in animal models, with some researchers suggesting it enhances lymph flow to the stomach, crucial for immune function.

Nonetheless, further human research is required to substantiate these effects and understand the underlying mechanisms.

Selank has been associated with increased IL-6 production in blood cells from depressed patients. IL-6 plays a role in inflammation and immune responses.

In addition, a cell-based study indicated that Selank promotes the release of interferons, which are vital anti-viral agents.

While Selank is proposed to offer some defense against certain viral infections, one animal study involving virus-infected mice did not demonstrate any antiviral benefits, raising questions about this potential application.